Nvidia, Pfizer lead $80 mln funding for Israeli medical AI tech firm CytoReason

Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Nvidia (NVDA.O) Pfizer (PFE.N) Thermo Fisher (TMO.N) and venture capital investor OurCrowd participated in the round, CytoReason said.